Stock comparison
DexCom
DXCM$31.33BHealthcare Market cap, Sector
SANOFI CONS HEALTHC IND L
SANOFICONR.NS$104.57BHealthcare Market cap, Sector
Overall winner
SANOFI CONS HEALTHC IND L
DXCM 07 SANOFICONR.NS
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
DXCM0wins
7winsSANOFICONR.NS
67C
B78
72B
A89
73B
B83
59D
B77
56D
A91
64C
A86
64C
A85
Side-by-side metrics
| Metric | DXCM | SANOFICONR.NS |
|---|---|---|
| Market cap | $31.33B | $104.57B Winner |
| P/E (TTM) | Winner: 24.6x | 44.2x |
| EV/EBIT | Winner: 25.4x | 31.8x |
| ROIC (TTM) | 18.03% | 59.15% Winner |
| Gross margin | 61.84% | 68.13% Winner |
| Net margin | 19.31% | 27.35% Winner |
| Revenue CAGR 5y | 17.47% | 27.01% Winner |
| EPS CAGR 5y | Winner: 39.82% | 20.67% |
| Debt / Equity | 0.5x | 0.1x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
DXCM leads on
- EPS CAGR 5y39.82%vs 20.67%+48%
- P/E (TTM)24.6xvs 44.2x+44%
- EV/EBIT25.4xvs 31.8x+20%
SANOFICONR.NS leads on
- Debt / Equity0.1xvs 0.5x+86%
- Market cap$104.57Bvs $31.33B+70%
- ROIC (TTM)59.15%vs 18.03%+70%
- Revenue CAGR 5y27.01%vs 17.47%+35%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.